Trial Profile
Examination of utility of fulvestrant 500mg intended for climacteric junior line relapse breast cancer patient
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Fulvestrant (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 05 Mar 2014 New trial record